We are live on ! Find out more
OGEN icon

Oragenics
OGEN

8 hedge funds and large institutions have $24.5M invested in Oragenics in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

21% more capital invested

Capital invested by funds: $20.2M → $24.5M (+$4.23M)

14% more funds holding

Funds holding: 7 → 8 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$163K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$122K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$81.5K
4
VKH
Virtu KCG Holdings
New York
+$81.5K
5
Northern Trust
Northern Trust
Illinois
+$40.7K

Top Sellers

Rank Fund Capital Flow
1
EEG
E.E. Geduld
-$34K

OGEN Hedge Fund Activity: Q3 2015 in Review

8 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2015, worth a combined $24.5M — up 21% from $20.2M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new OGEN positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $163K. The largest seller was E.E. Geduld, exiting entirely with an estimated $34K sold.

  • 8 institutional investors held Oragenics (OGEN) as of Q3 2015, up from 7 in Q2 2015.
  • Funds reported $24.5M of Oragenics stock for Q3 2015, up 21% quarter-over-quarter.
  • 2 funds opened new Oragenics positions in Q3 2015 and 1 closed out, a net change of +1 holder.
  • The largest Oragenics buyer in Q3 2015 was Vanguard Group, an estimated $163K added.
  • The largest Oragenics seller in Q3 2015 was E.E. Geduld, an estimated $34K sold.

Based on aggregated 13F filings for Q3 2015.